نتایج جستجو برای: nhl cell line model

تعداد نتایج: 3815069  

Journal: :Hematological Oncology 2021

Background: despite the development of new highly effective treatments in field Non-Hodgkin's lymphoma (NHL), allogeneic hematopoietic stem cell transplantation (alloHSCT) still remains a potentially curative option for virtually all type NHL. Due to concerns about its high toxicity, alloHSCT NHL is reserved as ultimate line treatment. Introduction reduced intensity conditioning regimens, usage...

Journal: :Journal of acquired immune deficiency syndromes 2010
Eric A Engels Ruth M Pfeiffer Ola Landgren Richard D Moore

HIV-infected persons treated with highly active antiretroviral therapy (HAART) continue to have elevated risk for non-Hodgkin lymphoma (NHL). We conducted a retrospective cohort study of NHL among patients at an urban HIV clinic (N = 3025). Proportional hazards models identified immunologic and virologic predictors of NHL. Sixty-five NHLs arose during 1989 to 2006. NHL incidence declined over t...

Journal: :Blood 1983
M Roper W M Crist R Metzgar A H Ragab S Smith K Starling J Pullen B Leventhal A A Bartolucci M D Cooper

Although childhood T-cell acute lymphocytic leukemia (T-ALL) and T-cell non-Hodgkin's lymphoma (T-NHL) have certain clinical features in common, T-ALL carries a notably poorer prognosis than does T-NHL. To determine whether the malignant cells from patients with these disorders are distinguishable, we examined bone marrow and/or blood from 51 children with T-ALL and tumor biopsy specimens from ...

Journal: :Journal of the National Cancer Institute. Monographs 2014
Lindsay M Morton Joshua N Sampson James R Cerhan Jennifer J Turner Claire M Vajdic Sophia S Wang Karin E Smedby Silvia de Sanjosé Alain Monnereau Yolanda Benavente Paige M Bracci Brian C H Chiu Christine F Skibola Yawei Zhang Sam M Mbulaiteye Michael Spriggs Dennis Robinson Aaron D Norman Eleanor V Kane John J Spinelli Jennifer L Kelly Carlo La Vecchia Luigino Dal Maso Marc Maynadié Marshall E Kadin Pierluigi Cocco Adele Seniori Costantini Christina A Clarke Eve Roman Lucia Miligi Joanne S Colt Sonja I Berndt Andrea Mannetje Anneclaire J de Roos Anne Kricker Alexandra Nieters Silvia Franceschi Mads Melbye Paolo Boffetta Jacqueline Clavel Martha S Linet Dennis D Weisenburger Susan L Slager

BACKGROUND Non-Hodgkin lymphoma (NHL), the most common hematologic malignancy, consists of numerous subtypes. The etiology of NHL is incompletely understood, and increasing evidence suggests that risk factors may vary by NHL subtype. However, small numbers of cases have made investigation of subtype-specific risks challenging. The International Lymphoma Epidemiology Consortium therefore underto...

Journal: :iranian journal of basic medical sciences 0
seyedeh alia moosavian biotechnology research center, nanotechnology research center, school of pharmacy, mashhad university of medical sciences, mashhad, iran mahmoud reza jaafari biotechnology research center, nanotechnology research center, school of pharmacy, mashhad university of medical sciences, mashhad, iran seyed mohammad taghdisi targeted drug delivery research center, school of pharmacy, mashhad university of medical sciences, mashhad, iran fatemeh mosaffa biotechnology research center, pharmacy school, mashhad university of medical sciences, mashhad, iran ali badiee nanotechnology research center, school of pharmacy, mashhad university of medical sciences, mashhad, iran khalil abnous pharmaceutical research center, school of pharmacy, mashhad university of medical sciences, mashhad, iran

objective(s): development of molecules that specifically recognize cancer cells is one of the major areas in cancer research. human epidermal growth factor receptor 2 (her2) is specifically expressed on the surface of breast cancer cells. her2 is associated with an aggressive phenotype and poor prognosis. in this study we aimed to isolate rna aptamers that specifically bind to her2 overexpressi...

Journal: :Blood 2003
Jobst Greeve Antje Philipsen Kristina Krause Wolfram Klapper Klaus Heidorn Brian E Castle Joe Janda Kenneth B Marcu Reza Parwaresch

Activation-induced cytidine deaminase (AID) induces somatic hypermutation (SHM), class switch recombination (CSR), and immunoglobulin gene conversion in B-lymphocytes. Here we report for the first time the expression of AID in healthy human B-lymphocytes and in B-cell non-Hodgkin lymphomas (B-NHL). AID mRNA expression in humans is restricted to the CD19(+)CD38(+)IgD(-) germinal center cells, na...

Journal: :Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 2012
Elena Vigliar Ciro Cipullo Paolo Todaro Giuseppe Giuffre Stefano Pepe

The association between some infections and non-Hodgkin lymphomas (NHL) is well known. Human T-cell leukemia/lymphoma virus type 1 (HTLV-1) was the first oncogenic human retrovirus to be discovered and has been found to be associated with adult T-cell leukemia/lymphoma (ATLL). Epstein-Barr virus (EBV) has consistently been linked to both endemic and sporadic Burkitt lymphoma (BL), as well as...

Journal: :Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011
Sophia S Wang Idan Menashe James R Cerhan Wendy Cozen Richard K Severson Scott Davis Amy Hutchinson Nathaniel Rothman Stephen J Chanock Leslie Bernstein Patricia Hartge Lindsay M Morton

BACKGROUND There is growing evidence linking genetic variations to non-Hodgkin lymphoma (NHL) etiology. To complement ongoing agnostic approaches for identifying susceptibility genes, we evaluated 488 candidate gene regions and their relation to risk for NHL and NHL subtypes. METHODS We genotyped 6,679 tag single nucleotide polymorphisms (SNPs) in 947 cases and 826 population-based controls f...

2016
Shankaranand Siddappa Bharatnur Usha Amirtham Chennagiri S Premalata Rekha V Kumar

BackgroundNonHodgkin lymphoma (NHL) is one of the most frequent malignancies in children and adolescents. It represents lymphoid malignancies with diverse clinicopathological and biological features. There are very few studies on the frequency and distribution of NHL in this age group classified according to the WHO classification of 2008. A total of 246 cases with lymphoma were diagnosed in pe...

2014
Rachel E. Rempel Xiaolei Jiang Paul Fullerton Tuan Zea Tan Jieru Ye Jieying Amelia Lau Seiichi Mori Jen-Tsan Chi Joseph R. Nevins Daphne R. Friedman

Human aggressive B-cell non-Hodgkin lymphomas (NHL) encompass the continuum between Burkitt lymphoma and diffuse large B-cell lymphoma (DLBCL), and display considerable clinical and biologic heterogeneity, most notably related to therapy response. We previously showed that lymphomas arising in the Em-Myc transgenic mouse are heterogeneous, mirroring genomic differences between Burkitt lymphoma ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید